Understanding Hepatitis: Knowledge Saves Lives
The Importance of World Hepatitis Day
On July 28, 2026, World Hepatitis Day will focus on the theme “Let’s Talk Facts” with the rallying cry “Hepatitis? Get Informed. Get Active.” The Deutsche Leberstiftung (German Liver Foundation) actively supports this initiative, organized by the World Hepatitis Alliance, advocating for increased awareness regarding viral hepatitis. Misinformation and prejudices prevent timely detection and treatment of infections caused by hepatitis B and C viruses, making education a key priority.
What is Hepatitis?
Hepatitis refers to the inflammation of the liver, which can be classified into acute and chronic forms. When this inflammation lasts more than six months, it is considered chronic hepatitis. The causes of hepatitis are diverse, with the most common being steatotic liver disease (often referred to as fatty liver), usually associated with metabolic issues like diabetes, as well as infections from hepatitis viruses A, B, C, D, and E.
The Alarming Statistics
Despite growing awareness, misconceptions about hepatitis viruses persist, contributing to the stigma faced by affected individuals. According to the World Health Organization (WHO), approximately 1.3 million deaths globally occur each year due to hepatitis virus infections. Many of these deaths could be prevented through vaccination, timely diagnosis, and effective treatments.
In April 2024, the WHO estimated that nearly 254 million people live with chronic hepatitis B and about 50 million with chronic hepatitis C worldwide. An estimated 1.5 million new hepatitis B infections and one million new hepatitis C infections occur annually. Chronic infections may remain asymptomatic for years, potentially leading to severe conditions like liver cirrhosis or hepatocellular carcinoma (HCC).
The Global Burden of Disease
Approximately 3,500 people die every day from viral hepatitis complications, highlighting the significant global health burden resulting from these viruses. This situation underscores the critical need for preventive measures, early diagnosis, and effective therapies.
Prevention, Early Detection, and Treatment Save Lives
Advancements in prevention and treatment options for viral hepatitis in recent years have been significant. Public awareness campaigns about transmission routes and risk factors have improved, alongside modern diagnostic methods and effective antiviral therapies. Effective vaccines are available for hepatitis A and B, and vaccination against hepatitis B provides protection against hepatitis D, which can only occur concurrent with hepatitis B infection.
Since 2014, hepatitis C can often be cured through a short, nearly side-effect-free therapy lasting eight to twelve weeks, utilizing direct-acting antiviral medications (DAAs). While chronic hepatitis B is typically not curable, it can often be effectively managed with available treatments. Promising research on new medications shows potential for curing hepatitis B, with one Phase III study demonstrating a cure in 20% of treated patients.
The Role of Screening
Screening for hepatitis B and C exemplifies how health policy shifts can save lives. Testing initiatives have led to the identification and timely treatment of thousands of previously unrecognized infections, advancing the WHO’s goals for hepatitis elimination. Since 2021, a one-time screening for hepatitis B and C has been part of mandatory health examinations for insured individuals in Germany.
Educational Outreach
The Deutsche Leberstiftung provides accessible informational brochures covering hepatitis B, C, D, and E, designed for patients, relatives, and the interested public. These materials clarify symptoms, transmission paths, diagnosis, and modern therapies—essential resources for destigmatizing hepatitis.
Conclusion
The call from Prof. Dr. Heiner Wedemeyer, Chairman of the Deutsche Leberstiftung, emphasizes the urgency of combating misinformation while encouraging individuals to learn about hepatitis. Recognizing and treating viral infections early can prevent severe complications, allowing many to lead fulfilling lives without the burdens of chronic liver disease. Engaging with available preventative measures and screening initiatives is crucial for achieving the WHO’s hepatitis elimination goals by 2030.
For more information and resources on viral hepatitis, individuals can visit the Deutsche Leberstiftung’s website to access updated materials and insights into liver health.
